Pure Global Cannabis Inc. Share Price Toronto S.E.
Equities
PURE.H
CA74625A1075
Pharmaceuticals
Sales 2017 | - | Sales 2018 | - | Capitalization | 24.16M 33.02M 1.93B |
---|---|---|---|---|---|
Net income 2017 | - 0 0 | Net income 2018 | -23M -31.44M -1.84B | EV / Sales 2017 * | - |
Net Debt 2017 | 211K 288K 16.89M | Net Debt 2018 | 4.49M 6.14M 359M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-0.72
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 83.64% |
Managers | Title | Age | Since |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 29/07/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 30/06/18 |
1st Jan change | Capi. | |
---|---|---|
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |